ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04612	Antigen processing and presentation	6/21	77/7206	5.83753215428e-08
ko05168	Herpes simplex infection	6/21	182/7206	9.46023831932e-06
ko05164	Influenza A	5/21	167/7206	9.48296987283e-05
ko05162	Measles	4/21	120/7206	0.000351586158152
ko03050	Proteasome	3/21	54/7206	0.000480936775384
ko05161	Hepatitis B	4/21	173/7206	0.00139490514444
ko05152	Tuberculosis	4/21	187/7206	0.00185914025809
ko04060	Cytokine-cytokine receptor interaction	4/21	191/7206	0.0020094253346
ko05340	Primary immunodeficiency	2/21	30/7206	0.00334999635541
ko05321	Inflammatory bowel disease (IBD)	2/21	56/7206	0.0113318462017
ko04217	Necroptosis	3/21	178/7206	0.0142077613452
ko04640	Hematopoietic cell lineage	2/21	64/7206	0.0146284636126
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/21	191/7206	0.017152272016
ko04062	Chemokine signaling pathway	3/21	201/7206	0.0196355104802
ko05140	Leishmaniasis	2/21	75/7206	0.0197529792414
ko05146	Amoebiasis	2/21	99/7206	0.033116851546
ko04620	Toll-like receptor signaling pathway	2/21	100/7206	0.0337340037827
ko04659	Th17 cell differentiation	2/21	106/7206	0.0375318118981